Frontiers in Aging Neuroscience,
Journal Year:
2021,
Volume and Issue:
13
Published: Dec. 3, 2021
Background:
Walking
in
the
“real
world”
involves
motor
and
cognitive
processes.
In
relation
to
this,
declines
both
function
cognition
contribute
age-related
gait
dysfunction.
Transcranial
direct
current
stimulation
(tDCS)
treadmill
walking
(STW)
have
potential
improve
gait,
particularly
during
dual-task
(DTW);
whilst
performing
a
task.
Our
aims
were
analyze
effects
of
combined
anodal
tDCS
+
STW
intervention
on
cortical
activity
DTW.
Methods:
Twenty-three
young
adults
(YA)
21
older
(OA)
randomly
allocated
active
or
sham
groups.
Participants
performed
5-min
mixed
(alternating
30
s
bouts
DTW)
before
after
20-min
STW.
Anodal
electrodes
placed
over
left
prefrontal
cortex
(PFC)
vertex
(Cz)
using
9
cm
2
at
0.6
mA.
Cortical
PFC,
primary
(M1),
premotor
(PMC),
supplementary
area
(SMA)
bilaterally
recorded
functional
near-infrared
spectroscopy
(fNIRS)
system.
Oxygenated
hemoglobin
(HbO
)
levels
analyzed
as
indicators
activity.
An
accelerometer
measured
parameters.
We
calculated
difference
between
DTW
for
HbO
applied
linear
models
which
included
age
group
(YA
vs.
OA),
condition
(sham
active),
time
(pre-
post-intervention)
fixed
effects.
Treadmill
belt
speed
was
covariate.
Partial
correlation
tests
also
performed.
Results:
A
main
effect
observed.
OA
displayed
higher
PFC
M1,
unilaterally
right
PMC
variability
than
YA.
M1
decreased
YA
following
There
no
overall
However,
negative
correlations
observed
changes
stride
length
intervention.
Conclusion:
Increased
multiple
areas
may
act
compensatory
mechanism.
Reduction
with
suggests
improved
neural
efficiency.
Frontiers in Neuroscience,
Journal Year:
2021,
Volume and Issue:
15
Published: April 9, 2021
Purpose:
This
systematic
review
aims
to
examine
the
efficacy
of
transcranial
direct
current
stimulation
(tDCS)
combined
with
physical
training
on
excitability
motor
cortex,
performance,
and
learning.
Methods:
A
search
was
performed
PubMed,
Web
Science,
EBSCO
databases
for
relevant
research
published
from
inception
August
2020.
Eligible
studies
included
those
that
used
a
randomized
controlled
design
reported
effects
tDCS
improve
motor-evoked
potential
(MEP),
dynamic
posture
stability
index
(DPSI),
reaction
time,
error
rate
participants
without
nervous
system
diseases.
The
risk
bias
assessed
by
Cochrane
assessment
tool.
Results:
Twenty-four
an
initial
yield
768
met
eligibility
criteria.
considered
low.
Results
showed
anodal
can
significantly
increase
MEP
amplitude,
decrease
DPSI,
muscle
strength,
time
in
learning
tasks.
Moreover,
gain
effect
is
greater
than
sham
training.
Conclusion:
effectively
results
encourage
further
understand
synergistic
Frontiers in Aging Neuroscience,
Journal Year:
2021,
Volume and Issue:
13
Published: Oct. 28, 2021
Background:
Parkinson's
disease
is
a
common
neurodegenerative
disorder
with
motor
and
non-motor
symptoms.
Recently,
as
adjuvant
therapy,
transcranial
direct
current
stimulation
(tDCS)
has
been
shown
to
improve
the
function
of
patients
(PD).
This
systematic
review
aimed
evaluate
existing
evidence
for
efficacy
tDCS
PD.
We
included
English
databases
(PubMed,
Cochrane
Library,
Embase,
Web
Science)
Chinese
[Wanfang
database,
China
National
Knowledge
Infrastructure
(CNKI),
Science
Technology
Journal
Database
(VIP),
Biology
Medicine
(CBM)]
without
restricting
year
publication.
Twenty-one
studies,
total
736
participants,
were
in
analysis.
Two
independent
researchers
extracted
data
characteristics
each
study.
There
was
significant
pooled
effect
size
(−1.29;
95%
CI
=
−1.60,
−0.98;
p
<
0.00001;
I
2
0%)
Unified
PD
Rating
Scale
(UPDRS)
Montreal
cognitive
assessment
(SMD
0.87,
0.50
1.24;
0%).
The
poor
observed
UPDRS
III
scores
−0.13;
−0.64,
0.38;
0.61;
77%),
similar
results
timed
up
go
(TUG)
test,
Berg
balance
scale,
gait
assessment.
this
meta-analysis
showed
that
there
insufficient
improves
However,
seemed
their
performance.
Further
multicenter
research
larger
sample
needed.
In
addition,
future
should
focus
on
determining
parameters
are
most
beneficial
functional
recovery
Frontiers in Neurology,
Journal Year:
2022,
Volume and Issue:
12
Published: Feb. 2, 2022
Alzheimer's
disease
(AD)
and
Parkinson's
(PD)
are
neurodegenerative
disorders
characterized
by
cognitive
impairment
functional
decline
increasing
with
progression.
Within
non-pharmacological
interventions,
transcranial
direct
current
stimulation
(tDCS)
might
represent
a
cost-effective
rehabilitation
strategy
to
implement
abilities
positive
implications
for
autonomy
quality-of-life
of
patients.
Our
systematic
review
aimed
at
evaluating
the
effects
tDCS
upon
cognition
in
people
suffering
from
AD
PD.
We
searched
randomized
controlled
trials
(RCTs)
into
PubMed,
Web
Science,
Cochrane
Library.
Three
authors
extracted
data
interest,
neuropsychological
tests
or
experimental
tasks
scores
as
outcome
measures.
A
total
17
RCTs
(10
7
PD)
were
included.
Compared
sham
stimulation,
may
improve
global
recognition
memory
patients
also
some
executive
functions
(i.e.,
divided
attention,
verbal
fluency,
reduction
sensitivity
interference)
Criticism
remains
about
benefits
other
investigated
domains.
Despite
preliminary
emerging
evidences,
larger
common
measures
long-term
follow-ups
establishing
longevity
observed
necessary
future
research
applied
psychology
field,
alongside
improved
clinical
guidelines
on
pertaining
electrodes
montage,
sessions
number,
duration
intensity
battery
be
used.
Neurorehabilitation and neural repair,
Journal Year:
2021,
Volume and Issue:
35(8), P. 717 - 728
Published: May 28, 2021
Background
Since
people
with
Parkinson
disease
(PD)
rely
on
limited
prefrontal
executive
resources
for
the
control
of
gait,
interventions
targeting
cortex
(PFC)
may
help
in
managing
PD-related
gait
impairments.
Transcranial
direct
current
stimulation
(tDCS)
can
be
used
to
modulate
PFC
excitability
and
improve
cognitive
functions
gait.
Objective
We
investigated
effects
adding
anodal
tDCS
applied
over
a
session
aerobic
exercise
cognition,
activity
while
walking
PD.
Methods
A
total
20
PD
participated
this
randomized,
double-blinded,
sham-controlled
crossover
study.
Participants
attended
two
30-minute
sessions
(cycling
at
moderate
intensity)
combined
different
conditions
(active-
or
sham-tDCS),
1
week
apart.
The
order
was
counterbalanced
across
sample.
Anodal
(2
mA
minutes
[active-tDCS]
10
s
[sham-tDCS])
targeted
most
affected
hemisphere.
Spatiotemporal
parameters,
functions,
were
assessed
before
immediately
after
each
session.
Results
Compared
pre-assessment,
participants
decreased
step
time
variability
(effect
size:
−0.4),
shortened
simple
choice
reaction
times
sizes:
−0.73
−0.57,
respectively),
increased
stimulated
hemisphere
0.54)
only
+
active-tDCS.
Conclusion
addition
led
immediate
positive
variability,
processing
speed,
Translational Neurodegeneration,
Journal Year:
2021,
Volume and Issue:
10(1)
Published: June 29, 2021
Abstract
Background
Gait
problems
are
an
important
symptom
in
Parkinson’s
disease
(PD),
a
progressive
neurodegenerative
disease.
Transcranial
direct
current
stimulation
(tDCS)
is
neuromodulatory
intervention
that
can
modulate
cortical
excitability
of
the
gait-related
regions.
Despite
increasing
number
tDCS
studies
PD,
efficacy
this
technique
for
improving
gait
has
not
been
systematically
investigated
yet.
Here,
we
aimed
to
explore
effects
on
based
available
experimental
studies.
Methods
Using
PRISMA
(Preferred
Reporting
Items
Systematic
Reviews
and
Meta-Analyses)
approach,
PubMed,
Web
Science,
Scopus,
PEDro
databases
were
searched
randomized
clinical
trials
assessing
effect
patients
with
PD.
Results
Eighteen
included
systematic
review.
Overall,
targeting
motor
cortex
supplementary
area
bilaterally
seems
be
promising
rehabilitation
Studies
dorosolateral
prefrontal
or
cerebellum
showed
more
heterogeneous
results.
More
needed
compare
different
protocols,
including
protocols
applying
alone
and/or
combination
conventional
treatment
Conclusions
approach
Anodal
over
areas
shown
positive
gait,
but
other
less
promising.
However,
heterogeneities
methods
results
have
made
it
difficult
draw
firm
conclusions.
Therefore,
explorations
required
optimize
efficacy.
Journal of Parkinson s Disease,
Journal Year:
2022,
Volume and Issue:
12(4), P. 1083 - 1113
Published: March 4, 2022
Parkinson’s
disease
(PD)
is
known
to
affect
the
brain
motor
circuits
involving
basal
ganglia
(BG)
and
induce,
among
other
signs,
general
slowness
paucity
of
movements.
In
upper
limb
movements,
PD
patients
show
a
systematic
prolongation
movement
duration
while
maintaining
sufficient
level
endpoint
accuracy.
appears
cause
impairments
not
only
in
execution,
but
also
initiation
planning,
as
revealed
by
abnormal
preparatory
activity
motor-related
areas.
Grasping
affected
well,
particularly
coordination
hand
aperture
with
transport
phase.
last
fifty
years,
numerous
behavioral
studies
attempted
clarify
mechanisms
underlying
these
anomalies,
speculating
on
plausible
role
that
BG-thalamo-cortical
circuitry
may
play
normal
pathological
control.
Still,
many
questions
remain
open,
especially
concerning
management
speed-accuracy
tradeoff
online
feedback
this
review,
we
summarize
literature
results
reaching
grasping
parkinsonian
patients.
We
analyze
relevant
hypotheses
origins
dysfunction,
focusing
control
aspects
involved
different
phases
corresponding
played
BG.
conclude
an
insight
into
innovative
stimulation
techniques
computational
models
recently
proposed,
which
might
be
helpful
further
clarifying
through
affects
Journal of Parkinson s Disease,
Journal Year:
2024,
Volume and Issue:
14(s1), P. S135 - S146
Published: April 9, 2024
Non-pharmacological
interventions,
including
cognitive-behavioral
therapy
(CBT),
non-invasive
brain
stimulation
(NIBS),
electroconvulsive
(ECT),
light
(LT),
and
physical
rehabilitation/exercise,
have
shown
promise
as
effective
approaches
to
treat
symptoms
of
depression
anxiety
in
individuals
with
Parkinson's
disease
(PD).
In
this
narrative
literature
overview,
we
discuss
the
state-of-the-art
regarding
these
treatment
options
address
future
perspectives
for
clinical
practice
research.
interventions
hold
PD.
There
is
meta-analytic
evidence
efficacy
CBT,
NIBS,
ECT,
LT,
exercise
on
improving
depressive
symptoms.
For
symptoms,
CBT
shows
large
effects
but
scientific
other
non-pharmacological
limited.
Importantly,
treatments
are
safe
no
or
mild
side-effects.
More
research
needed
tailor
individuals'
needs
combined
may
provide
synergistic
effects.We
conclude
that
should
be
considered
alternative
augmentative
pharmacological
neurosurgical